Oxycodone prodrug extended release- Ensysce Biosciences

Drug Profile

Oxycodone prodrug extended release- Ensysce Biosciences

Alternative Names: BIO-MD™ PF614; ER Oxycodone - Ensysce Biosciences; ER Oxycodone Bio-MD™ System; PF 614; PRF 06014; PRF06104

Latest Information Update: 31 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PharmacoFore
  • Developer Ensysce Biosciences
  • Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid mu receptor agonists; Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Pain

Most Recent Events

  • 29 Jan 2018 Oxycodone extended release- Ensysce Biosciences receives Fast Track designation for Pain [PO] in USA
  • 29 Jan 2018 Ensysce Biosciences completes a phase I trial in Pain (In volunteers) in USA (PO)
  • 04 Dec 2017 Ensysce Biosciences re-initiates a phase I trial in Pain (In volunteers) in USA (PO) (NCT02454712)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top